Reducing administrative burden is treated as a strategic lever to improve clinical throughput and patient care quality by ...

ACOs entering MSSP with higher spending were consistently more likely to earn bonuses—a gap that persisted after a 2017 ...

Employers use carve-outs and cash-pay channels to reduce GLP-1 costs, while Scripta’s Navigator helps members compare prices ...

Bhavana (Tina) Bhatnagar, DO, advocates for AI and diverse clinical trials to bridge equity gaps in precision oncology and value-based care.

Organ transplant recipients (OTRs) treated with azathioprine (AZA) face an increased risk for nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), according to an updated ...

Today, the FDA granted accelerated approval to zongertinib (Hernexeos; Boehringer Ingelheim Pharmaceuticals, Inc.) for an expanded indication for adults with unresectable or metastatic non-squamous ...

Both approaches identified hemoglobin as one of the most significant predictors of CKD risk. Additional top-ranked features included blood urea, sodium levels, red blood cell count, potassium, and ...

Low-cost, scalable interventions can improve first-fill adherence, reduce avoidable hospitalizations, and support patient-centered strategies.

The mood surrounding US HIV policy in 2026 is markedly different from the cautious optimism that defined much of the past decade. What had once felt like a steady march toward ending the domestic ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Emerging CRC diagnostic tools along with better public awareness could help reverse rising deaths in younger adults, says Jordan Karlitz, MD.

Sweeping federal funding cuts and stalled prevention efforts are unraveling hard-won gains in HIV research and access, warns Peter Staley.